Sarcoidosis: Impact of other illnesses on the presentation and management of multi-organ disease

Lung

Volumn 180, Issue 5, 2002, Pages 281-299

  Reynolds, H Y ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Associated malignancy; Digestive and gastroenterologic symptoms; Multi organ involvement; Other or co morbid illness; Respiratory occupational exposure

Indexed keywords

ADULT; ARTICLE; BODY BUILD; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COMORBIDITY; CROHN DISEASE; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DYSPNEA; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABLE COLON; LUNG CANCER; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SARCOIDOSIS; REVIEW;

ADULT; COMORBIDITY; FEMALE; HUMANS; MALE; OCCUPATIONAL EXPOSURE; SARCOIDOSIS;

EID: 0036362440     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004080000104     Document Type: Article

References (68)

1. Abe C, Iwai K, Mikami R, Hosoda Y (1984) Frequent isolation of Propionibacterium acnes from sarcoidosis lymph nodes. Zentralbl Bakteriol Mikrobiol Hyg [A] 256:541-547
2. Askling J, Grunewald J, Eklund A, et al (1999) Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med 160:1668-1672
3. Baughman RP, Lower EE (1997) Alternatives to corticosteroids in the treatment of sarcoidosis. Sarcoidosis Vasc Diff Lung Dis 14:121-130
4. Baughman RP, Teirstein AS, Judson MA, et al (2001) Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Grit Care Med 164:1885-1889
5. Besnier E (1889) Lupus pernio de la face: synovites fangeuses (scrofulo tuberculeuses) symmetriques des extremities superieures. Ann Dermato et Syph 10:333
6. Blasi F, Rizzato G, Gambacorta M, et al (1997) Failure to detect the presence of Chlamydia pneumoniae in sarcoid pathology specimens. Eur Respir J 10:2609-2611
7. Boeck C (1899) Multiple benign sarcoid of the skin. J Cutan Gen Urin Dis 17:543-550
8. Chang B, Steimel J, Moller DR, et al (2001) Depression in sarcoidosis. Am J Respir Crit Care Med 163:329-334
9. Costabel U (2001) Sarcoidosis: clinical update. Eur Respir J 18 (suppl 32):56S-68S
10. Coutas DB, Zumwalt RE, Black WC, Sobonya RE (1994) The epidemiology of interstitial lung disease. Am J Respir Crit Care Med 150:967-972
11. Cullen MR, Kominsky JR, Rossman MD, et al (1987) Chronic beryllium disease in a precious metal refinery - clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume. Am Rev Respir Dis 135:201-208
12. Dines DE, DeRemee RA, Green PA (1971) Sarcoidosis associated with regional enteritis (Crohn's Disease) - report of two cases. Minnesota Med 54:617-620
13. Donohue P (2002) Mystery illness attacks any organ. In: To your good health. The Patriot-News, Harrisburg, PA, June 17, pp D6
14. Ebe Y, Ikushima S, Yamaguchi T, et al (2000) Proliferative response of peripheral blood mononuclear cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 17:256-265
15. Efferen LS (2001) The challenge of sarcoidosis. Chest 120:697-699
16. Epstein PE, Dauber JH, Rossman MD, Daniele RP (1982) Bronchoalveolar lavage in a patient with chronic berylliosis: evidence for hypersensitivity pneumonitis. Ann Intern Med 97:213-216
17. Escofet X, Kang SP, Woods WGA (2001) Sarcoidosis and inflammatory bowel disease (letter). J Clin Gastroenterol 33:345-346
18. Gaede KI, Wilke G, Brade L, et al (2002) Anti-chlamydophila immunoglobulins prevalence in sarcoidosis and usual interstitial pneumoniae. Eur Respir J 19:267-274
19. Hunninghake GW, Crystal RG (1981) Pulmonary sarcoidosis - a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 305:429-434
20. Hunninghake GW, Costabel U (Co-Chairs) and Committee members from the American Thoracic Society, the European Respiratory Society and the World Association of Sarcoidosis and Other Disorders (1999) Statement on sarcoidosis. Am J Respir Crit Care Med 160:736-755
21. Hutchinson J (1898) On eruptions which occur in connection with gout-Mortimer's malady. Arch Surg 9:307-315
22. Irwin RS, Curley FJ, French CL (1990) Chronic cough: the spectrum and frequency of causes, key components of the digestive evaluation, and outcome of specific therapy. Am Rev Respir Dis 141:640-647
23. Ishige I, Usui Y, Takemura T, Eishi Y (1999) Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 354:120-123
24. Israel H (1979) Sarcoidosis. In: Simmons DH (ed) Current Pulmonology, vol. 1 Houghton Mifflin, Boston, pp 163-182
25. Israel HL, Goldstein RA (1973) Hepatic granulomatosis and sarcoidosis. Ann Intern Med 79:669-678
26. James DG (2002) Pioneers of sarcoidosis - Jonathan Hutchinson (1828-1913). Sarc Vasc Diffuse Lung Dis 19:120
27. Johns CJ, Michele TM (1999) The clinical management of sarcoidosis - a 50 year experience at the Johns Hopkins Hospital. Medicine 78:65-111
28. Johns CJ, Schonfeld SA, Scott PP, et al (1986) Longitudinal study of chronic sarcoidosis with low-dose maintenance corticosteroid therapy - outcome and complications. In: Johns C (ed) 10th International Conference on Sarcoidosis and Other Granulomatous Disorders, Ann NY Acad Sci 465:702-712
29. Judson MA, Baughman RP, Teirstein AS, et al (1999) Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. Sarcoidosis Vasc Diffuse Lung Dis 16:75-86
30. Kiely PDW, Rees DHE, Axford JS (1994) Crohn's and sarcoidosis: different manifestations of the same disease process? Br J Clin Pract 48:274-275
31. Kraft SC (1971) Crohn's disease and sarcoidosis. N Engl J Med 285:1259-1260 (editorial)
32. Lenner R, Schilero GJ, Padilla ML, Teirstein AS (2002) Sarcoidosis presenting in patients older than 50 years. Sarcoidosis Vasc Diffuse Lung Dis 19:143-147
33. Löfgren S (1953) Primary pulmonary sarcoidosis. I. Early signs and symptoms. Acta Med Scand 145:424-431
34. Longcope WT, Freiman DG (1952) A study of sarcoidosis. Medicine (Baltimore) 31:1-132
35. Mañá J, Gómez-Vaquero C, Montero A, et al (1999) Löfgren's syndrome revisited: a study of 186 patients. Am J Med 107:240-245
36. Mayock RL, Bertrand P, Morrison CE, Scott JH (1963) Manifestations of sarcoidosis - analysis of 145 patients, with a review of nine series selected from the literature. Am J Med 35:67-88
37. Maxwell PR, Mendall MA, Kumar D (1997) Irritable bowel syndrome. Lancet 350:1691-1695
38. McGrath DS, Goh N, Foley PJ, duBois RM (2001) Sarcoidosis: genes and microbes - soil or seed? Sarcoidosis Vasc Diffuse Lung Dis 18:149-164
39. Mills GD, Allen RK, Timms P (1998) Chlamydia pneumoniae DNA is not detectable within sarcoidosis tissue. Pathology 30:295-298
40. Mitchell DN, Scadding JG (1974) Sarcoidosis - state of the art. Am Rev Respir Dis 110:774-802
41. Moller DR, Chen ES (2002) What causes sarcoidosis? Curr Opin Pulm Med 8:429-434
42. Muther RS, McCarron DA, Bennett WM (1981) Renal manifestations of sarcoidosis. Arch Intern Med 141:643-645
43. Nakao K, Noma K, Sato B, et al (1978) Serum prolactin levels in eighty patients with sarcoidosis. Eur J Clin Invest 8:37-40
44. Newman LS, Rose CS, Maier LA (1997) Sarcoidosis - medical progress. N Engl J Med 336:1224-1234
45. Nilubol N, Taub PJ, Venturero M, et al (2001) Ulcerative colitis and sarcoidosis. Mt Sinai J Med 68:400-402
46. Olden KW (2002) Diagnosis of irritable bowel syndrome. Gastroenterology 122:1701-1714
47. Phear DN (1958) The relation between regional ileitis and sarcoidosis. Lancet 2:1250-1251
48. Pope CE (1994) Acid-reflux disorders. N Engl J Med 331:656-660
49. Puolakkainen M, Campbell LA, Kuo CC, Leinonen M, et al (1996) Serological response to Chlamydia pneumoniae in patients with sarcoidosis. J Infect 33:199-205
50. Reynolds HY, Fulmer JD, Kazmierowski JA, et al (1977) Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest 59:165-175
51. Reynolds HY (1989) Pulmonary sarcoidosis: Do cellular and immunochemical lung parameters exist that would separate subgroups of patients for prognosis? Sarcoidosis 6:1-4
52. Reynolds HY (1991) Hypersensitivity pneumonitis: correlation of cellular and immunology changes with clinical phases of disease. Lung 169:S109-S128
53. Reynolds HY (1998) Diagnostic and management strategies for diffuse interstitial lung disease. Chest 113:192-202
54. Reynolds HY (1998) Interstitial lung disease. In: Harrison's Principles of Internal Medicine, 14th ed, McGraw-Hill, New York, pp 1460-1466
55. Reynolds HY (2002) Modulating airway defenses against microbes. Curr Opin Pulm Med 8:154-165
56. Reynolds HY, Boehmer JP, Pheasant TR, Riley TR, Mackley CL, Miller JJ, Fan CY (2002) Multi-organ sarcoidosis - patient monitoring and management of major organ involvement. Lung (in press).
57. Reynolds HY, Zhang WJ, Chorney KA, Chorney MJ (2000) Creation of a patient repository for the genetic analysis of pulmonary sarcoidosis (abstract). Eur Resp J 16 (suppl 31):240-241
58. Ricker W, Clark M (1949) Sarcoidosis. A clinico-pathological review of three hundred cases, including twenty-two autopsies. Am J Clin Path 19:725-749
59. Rossman MD, Kern JA, Elias JA, et al, (1988) Proliferative response of bronchoalveolar lymphocytes to beryllium - a test for chronic beryllium disease. Ann Intern Med 108:687-693
60. Scadding JG (1961) Prognosis of intrathoracic sarcoidosis in England. Br Med J 2:1165-1172
61. Schaumann J (1924) Benign lymphogranuloma and its cutaneous manifestations. Br J Dermatol 36:515-544
62. Sharma AM, Kadakia J, Sharma OP (1992) Gastrointestinal sarcoidosis. Sem Respir Med 13:442-449
63. Siltzbach LE (1967) Sarcoidosis: clinical features and management. Med Clin N Am 51:483-502
64. Takashima M, Hanai H, Sato Y, et al (1998) Association of Crohn's ileitis with pulmonary and cutaneous sarcoidosis in a Japanese patient. Gastroenterol Endos 48:637-639
65. Tobin RW, Pope CE, Pellegrini CA, et al (1998) Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 10:1804-1808
66. Turkington RW, Macindoe JH (1972) Hyperprolactinemia in sarcoidosis. Ann Intern Med 76:545-549
67. Winterbauer RH, Belic N, Moores KD (1973) A clinical interpretation of bilateral hilar adenopathy. Ann Int Med 78:65-71
68. Yamamoto M, Sharma OP, Hosoda Y (1992) Special report: the 1991 descriptive definition of sarcoidosis. Sarcoidosis 9 (suppl 1):33-34